Who invested in Glycart Biotechnology AG?
Glycart Biotechnology AG's investors include Novartis Venture Fund, Gilde Healthcare, Global Life Science Ventures, DVC Deutsche Venture Capital and BioMedInvest, and 1 more on record.
Who invested in Glycart Biotechnology AG
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2003, from 1 source
- Latest round
- Series A, $14MNov 2003
- Investors
- 6
The rounds
- Nov 2003Series A$14M
Novartis Venture Fund
Gilde Healthcare
Global Life Science Ventures- DVC Deutsche Venture Capital
- BioMedInvest
Quest Capital Management, Inc .
From a historical funding record
The exit
ExitBuyerPriceWhen
AcquiredRocheundisclosedJul 2005
From historical deal records. Wrong? Tell us.
Everyone who backed them
DVC Deutsche Venture CapitalGrowth equity1round
BioMedInvestGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Glycart Biotechnology AG
How much has Glycart Biotechnology AG raised?
Glycart Biotechnology AG has raised $14M across 1 round since 2003.
When did Glycart Biotechnology AG last raise?
Glycart Biotechnology AG's most recent round was a Series A of $14M in Nov 2003.
What was Glycart Biotechnology AG's biggest round?
Its most recent round, $14M in Nov 2003, is also its largest on record.
Who backed Glycart Biotechnology AG first?
Glycart Biotechnology AG's first round on record, in Nov 2003, was backed by Novartis Venture Fund, Gilde Healthcare and Global Life Science Ventures and 3 others.
What stage is Glycart Biotechnology AG at?
Glycart Biotechnology AG's latest named round is a Series A, in Nov 2003.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.